CLINICAL_TRIALS
trial_result
· 2015-03-17
Clinical Trial Update: Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis [Phase 3]
Summary
Phase 3 clinical trial update for apremilast in active ankylosing spondylitis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Ankylosing Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-03-17